Clinical trial Recruiting at 1 site Interventional Ages 18 to 70

Using low-dose naltrexone to relieve pain in complex regional pain syndrome

Official title: Low-Dose Naltrexone for the Treatment of Complex Regional Pain Syndrome

Run by Stanford University · NCT02502162 · Data updated 2026-11-12

This study is testing if low-dose naltrexone can help people with complex regional pain syndrome feel less pain.

More Complex Regional Pain Syndromes trials

Quick facts

Study typeInterventional
Ages18 Years to 70 Years
SexAll
Enrollment120 (estimated)
SponsorStanford University
Academic / other
Locations1 site (Palo Alto, California)
StatusRecruiting
StartedJune 2015
Main results expectedJuly 2027
Study endsJuly 2027
Registry record updatedMay 29, 2025
Trial IDNCT02502162 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals diagnosed with upper and/or lower extremity CRPS who have been stable on treatment for at least one month and have had CRPS for a minimum of one year.

Probably not a fit

Patients with known allergies to naltrexone or naloxone, those using prescription opioids, or those who are currently pregnant may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effectiveness of low-dose naltrexone (LDN) in alleviating symptoms of complex regional pain syndrome (CRPS). Participants will be randomly assigned to receive either LDN or a placebo over several weeks. They will attend in-person or virtual visits and complete questionnaires to assess their symptoms and overall well-being. The goal is to determine if LDN can provide significant pain relief for individuals suffering from CRPS.

Why it matters

Potential benefit: If successful, this treatment could offer a new, effective option for managing pain in patients with complex regional pain syndrome.

How similar studies have gone: While the use of low-dose naltrexone is gaining interest, this specific application for CRPS is relatively novel and has not been extensively tested in prior studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Upper and/or lower extremity CRPS
* On stable treatment for 1 month
* CRPS for at least 1 year
* Meet the Budapest criteria for CRPS at time of the study.

Exclusion Criteria:

* Any known allergy to naltrexone or naloxone
* Use of prescription opioid analgesics or illegal opioid use
* Current or planned pregnancy.

Where it's running

  • Stanford University
    Palo Alto, California, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.